BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32165349)

  • 21. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.
    Lietman SA; Kalinchinko N; Deng X; Kohanski R; Levine MA
    Hum Mutat; 2006 Jul; 27(7):717-8. PubMed ID: 16786512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.
    Ueki Y; Tiziani V; Santanna C; Fukai N; Maulik C; Garfinkle J; Ninomiya C; doAmaral C; Peters H; Habal M; Rhee-Morris L; Doss JB; Kreiborg S; Olsen BR; Reichenberger E
    Nat Genet; 2001 Jun; 28(2):125-6. PubMed ID: 11381256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation of the SH3BP2 gene in an aggressive case of cherubism.
    Carvalho VM; Perdigão PF; Pimenta FJ; de Souza PE; Gomez RS; De Marco L
    Oral Oncol; 2008 Feb; 44(2):153-5. PubMed ID: 17368082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the SH3BP2 gene mutation in cherubism.
    Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
    Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
    Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
    Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.
    Lietman SA; Prescott NL; Hicks DG; Westra WH; Levine MA
    Clin Orthop Relat Res; 2007 Jun; 459():22-7. PubMed ID: 17545756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel c.1255G>T (p.D419Y) mutation in SH3BP2 gene causes cherubism in a Turkish family.
    Dinckan N; Guven Y; Kayserili H; Aktoren O; Uyguner OZ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):e42-6. PubMed ID: 23083484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptor protein 3BP2 and cherubism.
    Hatani T; Sada K
    Curr Med Chem; 2008; 15(6):549-54. PubMed ID: 18336269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
    Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
    Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
    Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
    Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2.
    Mukai T; Fujita S; Morita Y
    Cells; 2019 Feb; 8(2):. PubMed ID: 30813388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SH3BP2-related fibro-osseous disorders of the maxilla and mandible: A systematic review.
    Kueper J; Tsimbal C; Olsen BR; Kaban L; Liao EC
    Int J Oral Maxillofac Surg; 2022 Jan; 51(1):54-61. PubMed ID: 33941395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss-of-function
    Kittaka M; Mizuno N; Morino H; Yoshimoto T; Zhu T; Liu S; Wang Z; Mayahara K; Iio K; Kondo K; Kondo T; Hayashi T; Coghlan S; Teno Y; Doan AAP; Levitan M; Choi RB; Matsuda S; Ouhara K; Wan J; Cassidy AM; Pelletier S; Nampoothiri S; Urtizberea AJ; Robling AG; Ono M; Kawakami H; Reichenberger EJ; Ueki Y
    JBMR Plus; 2024 Jun; 8(6):ziae050. PubMed ID: 38699440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice.
    Kittaka M; Yoshimoto T; Schlosser C; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
    JBMR Plus; 2020 Jun; 4(6):e10352. PubMed ID: 32537546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.
    Carvalho VM; Perdigão PF; Amaral FR; de Souza PE; De Marco L; Gomez RS
    Oral Dis; 2009 Jan; 15(1):106-10. PubMed ID: 19017279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
    Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
    J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
    Deckert M; Prod'Homme V
    Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mutation detection in SH3BP2 gene in a cherubism family].
    Li CY; Yu SF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16836910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cherubism. A case report.
    Cariati P; Monsalve Iglesias F; Fernández Solís J; Valencia Laseca A; Martinez Lara I
    Reumatol Clin; 2017; 13(6):352-353. PubMed ID: 27427211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone dynamics and inflammation: lessons from rare diseases.
    Matsumoto Y; Rottapel R
    Immunol Med; 2020 Jun; 43(2):61-64. PubMed ID: 31999934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.